Good news for Indonesia's manufacturing industry. According to the Nikkei Indonesia Manufacturing Purchasing Managers' Index (PMI), compiled by IHS Markit, Indonesia's manufacturing expanded both in terms of new orders and production (albeit at softer rates) in September 2016. Growth of new export orders in fact touched a 46-month high. Indonesia's manufacturing PMI rose to a reading of 50.9 in September, up from 50.4 in the preceding month (a reading above 50.0 indicates expansion).

Lanjut baca ›

On 2 October 2016, Indonesia Investments released the latest edition of its newsletter. This free newsletter, which is sent to our subscribers once per week, contains the most important news stories from Indonesia that have been reported on our website over the last seven days. Most of the topics involve economy-related topics such as Indonesia's tax amnesty program, the pharmaceutical industry, GDP growth, the current account balance, competitiveness, urban planning, renewable energy, and more.

Lanjut baca ›

The first phase of Indonesia's tax amnesty program ended on Friday (30/09). Contrary to earlier forecasts the first phase of the program can be labeled a success. The Indonesian government collected IDR 97.2 trillion (approx. USD $7.5 billion) in additional tax revenue, or 58.9 percent of the nine-month program's full target (IDR 165 trillion). Indonesia's tax amnesty program, which runs up to 31 March 2017, is divided in three phases. In the first phase the government offered the most attractive tax tariffs to taxpayers who declare and/or repatriate their previously unreported assets.

Lanjut baca ›

Foreign pharmaceutical companies have already invested more than USD $1 billion in Indonesia over the past couple of years. These investments involves 34 companies that are all members of the International Pharmaceutical Manufacturers Group (IPMG). Parulian Simanjuntak, IPMG Executive Director, informed that these investments have been conducted not only to establish new factories but also for other forms of business expansion as well as marketing. It is estimated that 205 pharmaceutical companies are competing for market share in Indonesia.

Lanjut baca ›